LESKO, LJ. Use of biomarkers and surrogate erdpoints in drng development and regulatory decision making : criteria, Validation, strategies. Annu Rev Pharmacol Toxicol. 2001, 41, 347-366
VAN BOXTEL, CJ Eds. The In Vivo Study of Drug Action. 1992
WONG, SL. Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releaseing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer. Clin Pharmacol Ther. 2003, 73, 304-311